Effect of Cilostazol in Promoting Hematoma Clearance After Intracerebral Hemorrhage — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Cilostazol in Promoting Hematoma Clearance After Intracerebral Hemorrhage — Stella

Home/ICH - Intracerebral Hemorrhage/

View on ClinicalTrials.gov

Recruiting

Back to ICH - Intracerebral Hemorrhage trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Taiwan

National Taiwan University Hospital, Taipei, Not Required For This Country

Key details

Phase

Safety & dosing

Sponsor

National Taiwan University Hospital

Enrollment target

~100 participants

Started

June 2025

Primary completion

January 2027

Age range

20 Years – 80 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.